Vyvgart (efgartigimod alfa-fcab) is a prescription drug that’s used to treat myasthenia gravis (MG). Vyvgart comes as a liquid solution that’s given as an intravenous (IV) infusion. Doctors prescribe ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Please provide your email address to receive an email when new articles are posted on . The approval applies to certain patients with myasthenia gravis or chronic inflammatory demyelinating ...
Hosted on MSN
FDA Approves Self-Injection of Vyvgart Hytrulo
WEDNESDAY, April 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the ...
Vyvgart Hytrulo is a prescription drug used to treat certain conditions that affect your muscles and nerves. Vyvgart Hytrulo is given as an infusion under the skin by a doctor or another healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results